Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review

Background: People suffering from schizophrenia are notably vulnerable to cardiometabolic risk factors (CMRF), such as obesity, high blood pressure, hyperglycemia and insulin resistance, high serum triglycerides, and low serum high-density lipoprotein (HDL), which are related to increased mortality...

Full description

Bibliographic Details
Main Authors: Ewa Tumiel, Adam Wichniak, Marek Jarema, Michał Lew-Starowicz
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2019.00566/full